Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

US Government Launches Microbiome Research Initiative

XTALKS VITALS NEWS

Microbiome

Researchers have been increasingly identifying links between the microbiome and chronic diseases, including diabetes, asthma and obesity.

Share this!

May 16, 2016 | by Sarah Massey, M.Sc.

On Friday, the White House announced it would be funding a new public-private microbiome research fund, aimed at supporting the development of new therapies promoting healthy bacterial communities. The National Microbiome Initiative (NMI), will be overseen by the Science and Technology Policy group, along with other federal agencies and private companies.

The goal of the initiative is to “foster the integrated study of microbiomes across different ecosystems.” The NMI will be launched with over $121 million in funding for its first year of microbiome studies in human health and agriculture.

Microbiomes are composed of a variety of microorganisms which live in the body, the soil, the oceans, and even the atmosphere. They play a vital role in maintaining the health of humans, animals and the environment.



Researchers have been increasingly identifying links between the microbiome and chronic diseases, including diabetes, asthma and obesity. A better understanding of these microbial communities could lead to the development of new microbiome-targeted medicines.

“The NMI aims to advance understanding of microbiome behavior and enable protection and restoration of healthy microbiome function,” said a statement released by the White House. “In a year-long fact-finding process, scientists from Federal agencies, academia, and the private sector converged on three recommended areas of focus for microbiome science, which are now the goals of the NMI.”

The current goals of the project include developing platform technologies, supporting interdisciplinary research and expanding the workforce of the microbiome project. The Department of Energy, the National Institutes of Health (NIH) and the National Science Foundation are all chipping in to support the initiative.


Keywords: Microbiome, Chronic Disease, NIH


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News


PTC to Acquire Marathon’s Recently Approved Duchenne Muscular Dystrophy Drug

March 17, 2017 - Amid a drug pricing controversy, PTC Therapeutics has agreed to buy Marathon Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug, Emflaza.

Featured In: Pharmaceutical News


Memphis Meats Produces World’s First Poultry from Animal Cells

March 17, 2017 - Silicon Valley-based food manufacturing company, Memphis Meats, has produced the world’s first “clean poultry” by growing chicken and duck cells outside the animals.

Featured In: Food News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.